Cove Street Capital LLC Has $4.93 Million Stake in American Vanguard Corporation $AVD

Key Points

• Cove Street Capital LLC has increased its stake in American Vanguard Corporation by 35%, making it their largest holding at 7.7% of their portfolio.
• American Vanguard's recent earnings report showed it beating analysts' expectations with a loss of ($0.03) per share, despite a slightly lower revenue than predicted.
• Wall Street analysts hold an average rating of "Buy" for American Vanguard, with a target price of $12.00 per share, although some ratings have been adjusted to "hold."

Cove Street Capital LLC boosted its position in American Vanguard Corporation (NYSE:AVD - Free Report) by 35.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,119,539 shares of the basic materials company's stock after acquiring an additional 290,246 shares during the quarter. American Vanguard accounts for 7.7% of Cove Street Capital LLC's holdings, making the stock its largest holding. Cove Street Capital LLC owned 3.89% of American Vanguard worth $4,926,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in AVD. AQR Capital Management LLC boosted its holdings in shares of American Vanguard by 117.8% in the 1st quarter. AQR Capital Management LLC now owns 436,687 shares of the basic materials company's stock valued at $1,921,000 after purchasing an additional 236,212 shares in the last quarter. PDT Partners LLC bought a new stake in shares of American Vanguard during the 1st quarter worth $110,000. First Manhattan CO. LLC. acquired a new stake in American Vanguard in the first quarter valued at about $220,000. Trexquant Investment LP boosted its stake in American Vanguard by 415.6% in the first quarter. Trexquant Investment LP now owns 127,504 shares of the basic materials company's stock valued at $561,000 after buying an additional 102,774 shares in the last quarter. Finally, Ieq Capital LLC grew its position in American Vanguard by 46.5% in the first quarter. Ieq Capital LLC now owns 17,154 shares of the basic materials company's stock valued at $75,000 after acquiring an additional 5,448 shares during the last quarter. 79.00% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on AVD shares. Wall Street Zen raised shares of American Vanguard from a "hold" rating to a "buy" rating in a report on Friday. Lake Street Capital dropped their price objective on shares of American Vanguard from $14.00 to $12.00 and set a "buy" rating for the company in a research note on Monday, June 9th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of $12.00.

American Vanguard Trading Up 2.0%

Shares of AVD traded up $0.11 during mid-day trading on Monday, reaching $5.70. 200,761 shares of the company were exchanged, compared to its average volume of 231,649. American Vanguard Corporation has a 52 week low of $3.28 and a 52 week high of $6.68. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.00 and a current ratio of 1.91. The stock has a market capitalization of $162.05 million, a PE ratio of -1.28 and a beta of 1.26. The business has a 50 day simple moving average of $4.47 and a two-hundred day simple moving average of $4.37.

American Vanguard (NYSE:AVD - Get Free Report) last announced its earnings results on Thursday, July 31st. The basic materials company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.08. American Vanguard had a negative return on equity of 26.21% and a negative net margin of 23.72%.The business had revenue of $129.31 million for the quarter, compared to analysts' expectations of $130.00 million.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.